Get started
Author

Ankush Shetake

Observed names: A. Shetake, Ankush Gorakh Shetake
ORCID: 0009-0001-9162-602X
Observed ORCID: 0009-0001-9162-602X
OpenAlex ID: A5099775784
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)
2026 · Vanita Noronha, Vijay Patil, et al. · Journal of Clinical Oncology · 14
Genomic Profiling of Driver Gene Alterations in Patients With Non–Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center Experience of More Than 1200 Patients
2025 · Minit Shah, Vanita Noronha, et al. · Clinical Lung Cancer · 10
Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer
2024 · Vanita Noronha, Vijay Patil, et al. · International Journal of Radiation Oncology*Biology*Physics · 9
Phase III randomized study comparing ultra-low dose immunotherapy to standard cytotoxic chemotherapy for solid tumors in second line and beyond setting (DELII: Development of Low dose Immunotherapy in India).
2025 · Vanita Noronha, Nandini Sharrel Menon, et al. · Journal of Clinical Oncology · 6
PDF
A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer
2025 · Kumar Prabhash, Vanita Noronha, et al. · European Journal of Cancer · 4
Prevalence and impact of financial toxicity in older patients with cancer: a prospective observational study in India
2025 · Vanita Noronha, Arnav Tongaonkar, et al. · Supportive Care in Cancer · 4
PDF
Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial
2024 · Vanita Noronha, Nandini Menon, et al. · British Journal of Cancer · 3
PDF
MRI-based tumor signatures as prognostic biomarkers in oral tongue squamous cell carcinoma
2026 · Nivedita Chakrabarty, Nithin Krishnan, et al. · Frontiers in Oncology · 2
PDF
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial
2026 · Vanita Noronha, Minit Shah, et al. · JCO Global Oncology · 2
PDF
Neoadjuvant Chemotherapy and Low Dose Immunotherapy in Resectable Non-small Cell Lung Cancer: A Multi-center Retrospective Cohort Analysis
2025 · M. Shah, V. Noronha, et al. · Clinical Oncology · 2
Outcomes and toxicities of triple metronomic chemotherapy with low-dose nivolumab and axitinib in unresectable, recurrent, and metastatic head-and-neck squamous cell carcinomas: A real-world retrospective analysis from a resource-constrained setting
2026 · Rumeli Roy, Vanita Noronha, et al. · Cancer Research Statistics and Treatment · 1
Need and uptake of geriatric assessment-guided interventions in older Indian patients with cancer: A cross-sectional analytical study
2025 · Vanita Noronha, Anupa Pillai, et al. · Journal of Geriatric Oncology · 1
Efficacy and safety of taxane platinum doublet chemotherapy with triple oral metronomic chemotherapy and low dose nivolumab as neoadjuvant therapy in locally advanced head and neck squamous cell carcinoma.
2025 · Shriraj Shailesh Talati, Minit Jalan Shah, et al. · Journal of Clinical Oncology · 1
PDF
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy
2025 · Minit Shah, Sushmita Rath, et al. · JCO Global Oncology · 1
PDF
Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in India
2025 · Vanita Noronha, Jatin Choudhary, et al. · Journal of Geriatric Oncology · 1
Randomized trial of adjuvant 5-FU-platinum versus paclitaxel-platinum for high-risk penile cancer
2026 · Vanita Noronha, Nandini Menon, et al. · JNCI Journal of the National Cancer Institute
Evaluation of a modified Cumulative Illness Rating Scale-Geriatrics (CIRS-G) score in older adults with cancer
2026 · Anant Ramaswamy, Prashant Kumar, et al. · Journal of Geriatric Oncology
Reply to: Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab
2026 · Kumar Prabhash, Vanita Noronha, et al. · Journal of Clinical Oncology
Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma
2026 · Minit Shah, Vanita Noronha, et al. · Diseases of the Esophagus
Low-dose pembrolizumab with chemotherapy in advanced NSCLC: A phase 3 randomized trial.
2026 · Nandini Sharrel Menon, Vanita Noronha, et al. · Journal of Clinical Oncology
Screening for poor muscle strength in older Indian patients with solid tumor using SARC-F questionnaire and handgrip
2026 · Anupa Pillai, Anant Ramaswamy, et al. · Journal of Geriatric Oncology
Geriatric Oncology multidomain intervention study to prevent Cognitive impairment among older Indian patients with cancer receiving chemotherapy: a multicentric randomised controlled trial (GOCog)
2026 · Vanita Noronha, Nandini Menon, et al. · BMC Geriatrics
Vulnerability assessment and decision-making in older patients with head and neck cancers planned for chemoradiation: Experience from a Tertiary Care Cancer Centre in India
2026 · Vanita Noronha, Laboni Sarkar, et al. · Journal of Cancer Research and Therapeutics
Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers
2025 · Vallish Shenoy, Sadhana Kannan, et al. · Journal of Geriatric Oncology
Response to Letter Re: “A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer”
2025 · Kumar Prabhash, Vanita Noronha, et al. · European Journal of Cancer
Works count: 30
Citation count: 61
H-index: 4
I10-index: 2
Year
Topic
Type